A Cardinal Health unit has agreed to pay $10 million to resolve claims that it failed to report suspiciously large orders of addictive painkillers.
The death toll from alcohol poisoning in a Siberian city has risen to at least 52 after the victims consumed a bath lotion.
Jefferies lowers its 2017 Merck earnings-per-share estimate to $3.69 from $4.14.
Morgan Stanley expects Eli Lilly's sales will rise by 5 percent a year through 2020.
The pharmaceutical company wins its hepatitis C drug trial against Gilead Sciences.
Martin Andanar, secretary of the Presidential Communications Office of the Philippines, talks about the top concerns of the Duterte administration.
Martin Andanar, secretary of the Presidential Communications Office of the Philippines, weighs in on President Duterte's health and the country's foreign policy.
Woodcock approved Sarepta's drug against the wishes of others at the agency.
The leading causes remained heart disease, cancer, chronic lower respiratory diseases, unintentional injuries, stroke, and Alzheimer’s.
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry."
British regulators fine Pfizer and distributor Flynn Pharma for increasing the cost of an epilepsy drug by as much as 2,600-percent.
The "kill ratio" of suspects in The Philippines is much higher than in countries with comparable drug-related violence.
Kenneth Frazier, the CEO of pharmaceutical giant Merck, says Trump's call to revamp Obamacare could prove useful.
CNBC’s Meg Tirrell talks to Kenneth Frazier, Merck CEO, at the fifth annual Forbes Healthcare Summit in New York about the future of drug pricing under the Trump administration as well as Alzheimer’s research.
CNBC's Meg Tirrell speaks with Express Scripts chief medical officer Dr. Steve Miller about the role of pharmacy benefits managers in drug pricing.
The White House said in a statement after the House vote: "The Senate should promptly pass this bill so that the President can sign it." The bill, sponsored by Republican Representative Fred Upton of Michigan, authorizes $4.8 billion to the National Institutes of Health and $500 million to the Food and Drug Administration to streamline the clinical trial process...
Nov 30- The U.S. House of Representatives is poised to pass a sweeping, $6.3 billion bill that supporters say will spur medical innovation, speed access to new drugs, expand access to mental health treatment and battle the opioid epidemic. The Senate is expected to vote on it next week. The Act, sponsored by Republican representative Fred Upton from Michigan,...
Bernie Williams, USAA Investment Solutions CIO, weighs in on how to best prepare your portfolio and your retirement.
Rodrigo Duterte has hit out at what he called Western threats to seek an International Criminal Court indictment over alleged summary executions.
Alex Tarrant, assistant editor at Dealreporter Europe, weighs in on Johnson & Johnson's proposed acquisition of Swiss biotechnology company Actelion.